0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7290.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7382.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7384.

JAMA | 
Viewpoint |  FREE ONLINE FIRST
Humayun J. Chaudhry, DO, MS; Arthur S. Hengerer, MD; Gregory B. Snyder, MD
JAMA. Published online June 16, 2016. doi:10.1001/jama.2016.7741

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(22):2389. doi:10.1001/jama.2016.6599.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(22):2390. doi:10.1001/jama.2016.6962.

JAMA Pediatrics | 
Editorial |  ONLINE FIRST
Giulia Paolella, MD; Pietro Vajro, MD
JAMA Pediatr. Published online June 13, 2016. doi:10.1001/jamapediatrics.2016.0964

JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.
JAMA Psychiatry. Published online May 11, 2016. doi:10.1001/jamapsychiatry.2016.0538
Includes: Supplemental Content

JAMA | 
Editorial | 
Pranita D. Tamma, MD, MHS; Sara E. Cosgrove, MD, MS
JAMA. 2016;315(17):1839-1841. doi:10.1001/jama.2016.4286.

JAMA | 
Original Investigation | 
Katherine E. Fleming-Dutra, MD; Adam L. Hersh, MD, PhD; Daniel J. Shapiro; et al.
JAMA. 2016;315(17):1864-1873. doi:10.1001/jama.2016.4151.
Includes: CME, Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
New Fluoroquinolone Warning
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA
Viewpoint  | 
Medical Board Expectations for Physicians Recommending Marijuana
Humayun J. Chaudhry, DO, MS; Arthur S. Hengerer, MD; Gregory B. Snyder, MD